Concepedia

J. Wernicke

JW

5

Publications

528

Citations

5

H-Index

1988

Active since

Affiliations

Eli Lilly (United States)(Current)

J. Wernicke is an author at Eli Lilly (United States) specializing in psychiatry, social sciences, and neuropharmacology.

Top concepts

MedicineDepressionPsychiatryMental HealthPsychopathologySocial SciencesNeuropharmacologyBiological PsychiatryNeurosciencePharmacology

Publications per year

1988–2006

5

Publications

5

A Comparison of Fluoxetine Imipramine and Placebo in Patients with Bipolar Depressive Disorder

Jay B. Cohn, G. H. Collins, EARLEEN ASHBROOK et al. · International Clinical Psychopharmacology · 1989 · 256 citations

Duloxetine versus Routine Care in the Long-Term Management of Diabetic Peripheral Neuropathic Pain

Joel Raskin, Timothy R. Smith, Kar Lok Wong et al. · Journal of Palliative Medicine · 2006 · 118 citations · Full text

The Evidence for 20 mg a day of Fluoxetine as the Optimal Dose in the Treatment of Depression

A. Carlo Altamura, Stuart Montgomery, J. Wernicke · The British Journal of Psychiatry · 1988 · 84 citations

Dose Level, Pharmacological Study, Psychiatry +15

Pattern analysis shows beneficial effect of fluoxetine treatment in mild depression.

S R Dunlop, Bruce E. Dornseif, J. Wernicke et al. · PubMed · 1990 · 59 citations

Hamilton Rating Scale, Psychiatry, Mood Symptom +15

Antidepressants

J. Wernicke, A. Rosen, Yifei Lü et al. · Journal of Pain · 2004 · 11 citations

Rows per page

1–5 of 5